Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New thrombin inhibitors from Merck & Co. for thromboembolic disorders

Nov. 16, 1998

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Nov. 16, 1998

First IND filed by Avigen for hemophilia B gene therapy

Nov. 12, 1998

LY-203638 has potent profibrinolytic effects in canine model of thrombosis

Nov. 10, 1998

APLAUD study evaluates SB-214857 in patients with coronary artery and cerebrovascular disease

Nov. 9, 1998

YM-75466 possesses significant advantages over warfarin as oral anticoagulant

Nov. 6, 1998

Potential new antithrombotic agent profiled, structure revealed

Nov. 4, 1998

Hungarian research team presents new antithrombotic thioglycosides

Nov. 2, 1998

Japan Tobacco obtains rights to Terumo antiplatelet agent

Oct. 30, 1998

Ajinomoto prepares extensive series with anticoagulant efficacy

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026